Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Crinetics Pharmaceuticals (CRNX) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Crinetics Pharmaceuticals (CRNX) over the last 8 years, with Q3 2025 value amounting to 0.0.

  • Crinetics Pharmaceuticals' Asset Utilization Ratio rose 1132.11% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year increase of 1132.11%. This contributed to the annual value of 0.0 for FY2024, which is 8764.8% down from last year.
  • According to the latest figures from Q3 2025, Crinetics Pharmaceuticals' Asset Utilization Ratio is 0.0, which was up 1132.11% from 0.0 recorded in Q2 2025.
  • Crinetics Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.02 during Q2 2023, with a 5-year trough of 0.0 in Q1 2025.
  • In the last 5 years, Crinetics Pharmaceuticals' Asset Utilization Ratio had a median value of 0.01 in 2023 and averaged 0.01.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 93978.7% in 2021, then plummeted by 9090.82% in 2024.
  • Over the past 5 years, Crinetics Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then soared by 234.09% to 0.01 in 2022, then tumbled by 51.1% to 0.01 in 2023, then crashed by 86.06% to 0.0 in 2024, then soared by 40.98% to 0.0 in 2025.
  • Its Asset Utilization Ratio was 0.0 in Q3 2025, compared to 0.0 in Q2 2025 and 0.0 in Q1 2025.